Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELF3
|
ENSG00000163435.11 | E74 like ETS transcription factor 3 |
EHF
|
ENSG00000135373.8 | ETS homologous factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_34640874_34641025 | EHF | 1709 | 0.490965 | -0.71 | 3.4e-02 | Click! |
chr11_34641232_34641383 | EHF | 1351 | 0.567238 | -0.69 | 4.0e-02 | Click! |
chr11_34666038_34666189 | EHF | 1939 | 0.464149 | 0.57 | 1.1e-01 | Click! |
chr11_34707081_34707232 | EHF | 42982 | 0.190316 | 0.56 | 1.1e-01 | Click! |
chr11_34606696_34606847 | EHF | 35887 | 0.188080 | -0.51 | 1.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_49229748_49230219 | 1.36 |
MAMSTR |
MEF2 activating motif and SAP domain containing transcriptional regulator |
7005 |
0.09 |
chr6_5582433_5582584 | 1.27 |
RP1-256G22.2 |
|
112997 |
0.06 |
chr12_92172292_92172567 | 0.91 |
C12orf79 |
chromosome 12 open reading frame 79 |
358368 |
0.01 |
chr3_197243853_197244178 | 0.89 |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
2749 |
0.36 |
chr17_79544376_79544572 | 0.88 |
ENSG00000207021 |
. |
3958 |
0.12 |
chr13_114563717_114564199 | 0.84 |
GAS6 |
growth arrest-specific 6 |
3082 |
0.32 |
chr12_53646222_53647285 | 0.83 |
MFSD5 |
major facilitator superfamily domain containing 5 |
873 |
0.43 |
chr1_42092263_42092414 | 0.77 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
74334 |
0.1 |
chrX_2546999_2547150 | 0.76 |
CD99P1 |
CD99 molecule pseudogene 1 |
19618 |
0.22 |
chr21_31276988_31277139 | 0.76 |
GRIK1 |
glutamate receptor, ionotropic, kainate 1 |
34755 |
0.21 |
chr1_94607480_94607631 | 0.76 |
RP11-78O9.1 |
|
3112 |
0.21 |
chr20_35214114_35214400 | 0.75 |
TGIF2 |
TGFB-induced factor homeobox 2 |
6929 |
0.12 |
chr10_69865393_69865544 | 0.75 |
MYPN |
myopalladin |
444 |
0.84 |
chr3_197244192_197244451 | 0.74 |
BDH1 |
3-hydroxybutyrate dehydrogenase, type 1 |
3055 |
0.34 |
chr12_92168554_92168767 | 0.74 |
C12orf79 |
chromosome 12 open reading frame 79 |
362137 |
0.01 |
chr12_46285760_46285911 | 0.72 |
ENSG00000265093 |
. |
18023 |
0.21 |
chr1_20062070_20062221 | 0.71 |
TMCO4 |
transmembrane and coiled-coil domains 4 |
63692 |
0.08 |
chr13_30250804_30250955 | 0.71 |
SLC7A1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
81054 |
0.11 |
chr4_102077826_102078189 | 0.71 |
ENSG00000221265 |
. |
173564 |
0.03 |
chr4_7807672_7807823 | 0.70 |
AFAP1-AS1 |
AFAP1 antisense RNA 1 |
51930 |
0.13 |
chr5_10786958_10787253 | 0.69 |
CTD-2154B17.4 |
|
19369 |
0.22 |
chr2_1158720_1158941 | 0.68 |
AC114808.2 |
|
2720 |
0.39 |
chr7_100729983_100730493 | 0.68 |
TRIM56 |
tripartite motif containing 56 |
1435 |
0.28 |
chr1_8427807_8428006 | 0.67 |
RERE |
arginine-glutamic acid dipeptide (RE) repeats |
3008 |
0.25 |
chr3_115508198_115508490 | 0.67 |
ENSG00000243359 |
. |
48371 |
0.19 |
chr11_130717130_130717402 | 0.67 |
SNX19 |
sorting nexin 19 |
46503 |
0.19 |
chr6_158435644_158436349 | 0.66 |
SYNJ2 |
synaptojanin 2 |
2501 |
0.29 |
chr7_22707827_22707978 | 0.66 |
AC002480.5 |
|
6491 |
0.2 |
chr22_31502717_31502868 | 0.65 |
SELM |
Selenoprotein M |
762 |
0.5 |
chr3_170431668_170431819 | 0.65 |
RP11-373E16.3 |
|
57392 |
0.14 |
chr5_111290299_111290450 | 0.65 |
NREP-AS1 |
NREP antisense RNA 1 |
14624 |
0.23 |
chr7_148510468_148510619 | 0.64 |
ENSG00000251712 |
. |
7561 |
0.21 |
chr11_75186597_75187340 | 0.64 |
GDPD5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1928 |
0.27 |
chr12_76345410_76345561 | 0.64 |
ENSG00000243420 |
. |
6425 |
0.27 |
chr2_73248670_73248821 | 0.63 |
SFXN5 |
sideroflexin 5 |
50057 |
0.13 |
chr20_33168242_33168500 | 0.62 |
MAP1LC3A |
microtubule-associated protein 1 light chain 3 alpha |
21849 |
0.16 |
chr9_114795064_114795215 | 0.62 |
RP11-4O1.2 |
|
3451 |
0.26 |
chr4_100305460_100305611 | 0.62 |
ADH7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
45913 |
0.13 |
chr16_53290719_53290870 | 0.61 |
ENSG00000212582 |
. |
5959 |
0.22 |
chr9_126840949_126841100 | 0.61 |
RP11-85O21.5 |
|
46221 |
0.13 |
chr16_90124266_90124417 | 0.61 |
PRDM7 |
PR domain containing 7 |
4392 |
0.15 |
chr22_41577744_41578068 | 0.61 |
RP1-85F18.6 |
|
1242 |
0.33 |
chr10_93047253_93047404 | 0.61 |
PCGF5 |
polycomb group ring finger 5 |
66783 |
0.14 |
chr2_121310341_121310492 | 0.60 |
LINC01101 |
long intergenic non-protein coding RNA 1101 |
86719 |
0.09 |
chr6_12149127_12149412 | 0.60 |
HIVEP1 |
human immunodeficiency virus type I enhancer binding protein 1 |
23290 |
0.26 |
chr19_13282896_13283321 | 0.60 |
CTC-250I14.6 |
|
18101 |
0.1 |
chr6_2433057_2433208 | 0.60 |
ENSG00000266252 |
. |
23263 |
0.27 |
chr13_106572929_106573080 | 0.60 |
ENSG00000252550 |
. |
23012 |
0.28 |
chr17_45940314_45940519 | 0.60 |
SP6 |
Sp6 transcription factor |
7176 |
0.11 |
chr9_114822366_114822517 | 0.59 |
RP11-4O1.2 |
|
22431 |
0.18 |
chr17_35790342_35790493 | 0.59 |
RP11-378E13.4 |
|
21736 |
0.13 |
chrY_19190221_19190372 | 0.59 |
ENSG00000252315 |
. |
479448 |
0.01 |
chr10_33667177_33667328 | 0.59 |
NRP1 |
neuropilin 1 |
42062 |
0.2 |
chr9_97785527_97785678 | 0.58 |
C9orf3 |
chromosome 9 open reading frame 3 |
18324 |
0.17 |
chr16_83546506_83546657 | 0.58 |
ENSG00000263785 |
. |
4630 |
0.31 |
chr1_43740162_43740511 | 0.58 |
TMEM125 |
transmembrane protein 125 |
3719 |
0.16 |
chr5_150403062_150403457 | 0.58 |
GPX3 |
glutathione peroxidase 3 (plasma) |
1646 |
0.38 |
chr10_54076004_54076155 | 0.57 |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
2023 |
0.34 |
chr16_70727560_70727766 | 0.57 |
VAC14 |
Vac14 homolog (S. cerevisiae) |
1833 |
0.27 |
chr6_33150940_33151371 | 0.57 |
COL11A2 |
collagen, type XI, alpha 2 |
9076 |
0.08 |
chr1_167744512_167744663 | 0.57 |
MPZL1 |
myelin protein zero-like 1 |
9780 |
0.23 |
chrY_2497032_2497183 | 0.57 |
ENSG00000251841 |
. |
155683 |
0.04 |
chr13_98827271_98827422 | 0.56 |
RNF113B |
ring finger protein 113B |
2173 |
0.25 |
chr4_123463462_123463613 | 0.56 |
IL21-AS1 |
IL21 antisense RNA 1 |
76601 |
0.09 |
chr15_58472305_58472456 | 0.56 |
ALDH1A2 |
aldehyde dehydrogenase 1 family, member A2 |
41356 |
0.17 |
chr12_54535181_54535332 | 0.56 |
RP11-834C11.8 |
|
21667 |
0.1 |
chr7_46623249_46623400 | 0.56 |
AC011294.3 |
Uncharacterized protein |
113396 |
0.07 |
chr4_114469023_114469332 | 0.56 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
30378 |
0.23 |
chrX_2546788_2546939 | 0.56 |
CD99P1 |
CD99 molecule pseudogene 1 |
19407 |
0.22 |
chr5_54021842_54021993 | 0.56 |
ENSG00000221073 |
. |
126859 |
0.05 |
chr7_27957571_27957722 | 0.56 |
ENSG00000265382 |
. |
37540 |
0.18 |
chr1_207070153_207070445 | 0.55 |
IL24 |
interleukin 24 |
489 |
0.76 |
chr11_96053974_96054125 | 0.55 |
ENSG00000266192 |
. |
20553 |
0.19 |
chr11_702778_703267 | 0.55 |
EPS8L2 |
EPS8-like 2 |
2195 |
0.14 |
chr4_114331846_114332109 | 0.55 |
ENSG00000239279 |
. |
9019 |
0.21 |
chr15_100651163_100651491 | 0.55 |
ADAMTS17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
2015 |
0.33 |
chr6_111914585_111914879 | 0.55 |
C6orf3 |
|
6346 |
0.18 |
chr7_55093290_55093441 | 0.55 |
EGFR |
epidermal growth factor receptor |
6554 |
0.32 |
chr8_820510_820661 | 0.54 |
ERICH1-AS1 |
ERICH1 antisense RNA 1 |
12613 |
0.29 |
chr20_37601836_37601987 | 0.54 |
DHX35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
10924 |
0.19 |
chr3_48633214_48633365 | 0.54 |
COL7A1 |
collagen, type VII, alpha 1 |
589 |
0.56 |
chr2_228683348_228683499 | 0.54 |
CCL20 |
chemokine (C-C motif) ligand 20 |
4853 |
0.24 |
chr4_99443439_99443625 | 0.54 |
RP11-724M22.1 |
|
26017 |
0.24 |
chr2_106012016_106012167 | 0.54 |
FHL2 |
four and a half LIM domains 2 |
1151 |
0.51 |
chr13_100469124_100469275 | 0.54 |
ENSG00000238305 |
. |
32788 |
0.14 |
chr5_125700193_125700466 | 0.54 |
GRAMD3 |
GRAM domain containing 3 |
4505 |
0.33 |
chr11_3414358_3414509 | 0.53 |
TSSC2 |
tumor suppressing subtransferable candidate 2 pseudogene |
8556 |
0.16 |
chr17_39533966_39534194 | 0.53 |
KRT34 |
keratin 34 |
4575 |
0.1 |
chr6_116878944_116879095 | 0.53 |
FAM26D |
family with sequence similarity 26, member D |
4106 |
0.16 |
chr18_48594327_48594478 | 0.53 |
SMAD4 |
SMAD family member 4 |
919 |
0.65 |
chr6_159625174_159625325 | 0.53 |
FNDC1 |
fibronectin type III domain containing 1 |
6770 |
0.22 |
chr12_50582386_50582613 | 0.52 |
RP3-405J10.3 |
|
2647 |
0.18 |
chr5_993802_993953 | 0.52 |
RP11-43F13.3 |
|
3139 |
0.18 |
chr22_41913477_41913628 | 0.52 |
POLR3H |
polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) |
26897 |
0.11 |
chr5_443811_444333 | 0.52 |
EXOC3 |
exocyst complex component 3 |
689 |
0.42 |
chr14_69015321_69015580 | 0.52 |
CTD-2325P2.4 |
|
79712 |
0.1 |
chr1_220543285_220543436 | 0.52 |
AC096644.1 |
Uncharacterized protein |
64663 |
0.12 |
chr4_17157300_17157451 | 0.52 |
ENSG00000206780 |
. |
165130 |
0.04 |
chrY_2496783_2496934 | 0.52 |
ENSG00000251841 |
. |
155932 |
0.04 |
chr7_76209420_76209603 | 0.52 |
AC004980.7 |
|
30576 |
0.14 |
chr10_18970620_18970771 | 0.51 |
ARL5B |
ADP-ribosylation factor-like 5B |
22361 |
0.18 |
chr18_64969128_64969279 | 0.51 |
ENSG00000265580 |
. |
5684 |
0.34 |
chr4_102076936_102077087 | 0.51 |
ENSG00000221265 |
. |
174560 |
0.03 |
chr12_132629387_132630333 | 0.51 |
NOC4L |
nucleolar complex associated 4 homolog (S. cerevisiae) |
551 |
0.6 |
chr11_111428999_111429150 | 0.51 |
LAYN |
layilin |
16797 |
0.12 |
chr15_59484586_59484737 | 0.51 |
LDHAL6B |
lactate dehydrogenase A-like 6B |
14381 |
0.1 |
chr2_171877533_171877784 | 0.51 |
TLK1 |
tousled-like kinase 1 |
45788 |
0.16 |
chr5_34793787_34793938 | 0.51 |
RAI14 |
retinoic acid induced 14 |
36445 |
0.15 |
chr6_52794508_52794659 | 0.51 |
GSTA3 |
glutathione S-transferase alpha 3 |
20100 |
0.14 |
chr7_129214409_129214560 | 0.50 |
NRF1 |
nuclear respiratory factor 1 |
37071 |
0.16 |
chr6_21635140_21635291 | 0.50 |
SOX4 |
SRY (sex determining region Y)-box 4 |
41144 |
0.23 |
chr4_73836894_73837045 | 0.50 |
ENSG00000252955 |
. |
6074 |
0.28 |
chr17_70400916_70401067 | 0.50 |
ENSG00000200783 |
. |
259300 |
0.02 |
chr4_187858227_187858378 | 0.50 |
ENSG00000252382 |
. |
79692 |
0.12 |
chr1_16508178_16508413 | 0.50 |
ARHGEF19-AS1 |
ARHGEF19 antisense RNA 1 |
16054 |
0.1 |
chr5_60746303_60746454 | 0.50 |
ENSG00000223200 |
. |
106732 |
0.07 |
chr4_84772325_84772476 | 0.50 |
ENSG00000201633 |
. |
214957 |
0.02 |
chr6_44617686_44617874 | 0.50 |
ENSG00000266619 |
. |
214402 |
0.02 |
chr10_65459135_65459462 | 0.50 |
REEP3 |
receptor accessory protein 3 |
178175 |
0.03 |
chr5_67851115_67851266 | 0.50 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
262794 |
0.02 |
chr3_159646010_159646245 | 0.50 |
IL12A |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
60410 |
0.11 |
chr6_35336356_35336745 | 0.50 |
PPARD |
peroxisome proliferator-activated receptor delta |
26148 |
0.17 |
chr11_19454188_19454339 | 0.50 |
ENSG00000200687 |
. |
30735 |
0.16 |
chr12_112741045_112741373 | 0.50 |
ENSG00000201428 |
. |
36328 |
0.15 |
chr8_48282043_48282194 | 0.49 |
SPIDR |
scaffolding protein involved in DNA repair |
70845 |
0.12 |
chr9_134297878_134298101 | 0.49 |
PRRC2B |
proline-rich coiled-coil 2B |
7488 |
0.21 |
chr12_106328417_106328568 | 0.49 |
NUAK1 |
NUAK family, SNF1-like kinase, 1 |
149319 |
0.04 |
chr5_9047213_9047364 | 0.49 |
ENSG00000266415 |
. |
6719 |
0.29 |
chr8_18576151_18576302 | 0.49 |
RP11-161I2.1 |
|
2189 |
0.39 |
chr15_101807298_101807582 | 0.49 |
VIMP |
VCP-interacting membrane protein |
10052 |
0.15 |
chr1_204120333_204120989 | 0.49 |
ETNK2 |
ethanolamine kinase 2 |
105 |
0.95 |
chr12_15784098_15784249 | 0.49 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
31035 |
0.18 |
chr11_123416952_123417103 | 0.49 |
GRAMD1B |
GRAM domain containing 1B |
13943 |
0.24 |
chr20_47600336_47600487 | 0.49 |
ARFGEF2 |
ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) |
61984 |
0.11 |
chr5_171577540_171578134 | 0.48 |
STK10 |
serine/threonine kinase 10 |
37553 |
0.15 |
chr12_118491226_118491400 | 0.48 |
WSB2 |
WD repeat and SOCS box containing 2 |
904 |
0.6 |
chr21_29020046_29020197 | 0.48 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
681289 |
0.0 |
chr5_157284729_157285205 | 0.48 |
CLINT1 |
clathrin interactor 1 |
1174 |
0.54 |
chr3_128016629_128016780 | 0.48 |
ENSG00000221067 |
. |
64304 |
0.11 |
chr16_82049768_82049919 | 0.48 |
SDR42E1 |
short chain dehydrogenase/reductase family 42E, member 1 |
4750 |
0.21 |
chrY_19182245_19182396 | 0.48 |
ENSG00000252315 |
. |
487424 |
0.01 |
chr3_64206079_64206230 | 0.48 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
4977 |
0.24 |
chr1_235122781_235123123 | 0.48 |
ENSG00000239690 |
. |
83019 |
0.09 |
chr2_145765235_145765386 | 0.48 |
ENSG00000253036 |
. |
327328 |
0.01 |
chr8_121668070_121668250 | 0.48 |
RP11-713M15.1 |
|
105333 |
0.07 |
chr8_1941875_1942026 | 0.48 |
KBTBD11 |
kelch repeat and BTB (POZ) domain containing 11 |
19906 |
0.23 |
chr15_62899162_62899394 | 0.48 |
RP11-625H11.1 |
Uncharacterized protein |
38102 |
0.16 |
chr1_68849766_68849917 | 0.48 |
RPE65 |
retinal pigment epithelium-specific protein 65kDa |
65801 |
0.12 |
chr18_56215287_56215438 | 0.48 |
RP11-126O1.2 |
|
8940 |
0.17 |
chr19_18589481_18589960 | 0.48 |
ELL |
elongation factor RNA polymerase II |
2977 |
0.14 |
chr11_32234638_32234789 | 0.48 |
RP1-65P5.3 |
|
108076 |
0.06 |
chr19_18673575_18673726 | 0.48 |
KXD1 |
KxDL motif containing 1 |
749 |
0.36 |
chr13_99224014_99224442 | 0.47 |
STK24 |
serine/threonine kinase 24 |
4889 |
0.23 |
chr10_62606007_62606158 | 0.47 |
CDK1 |
cyclin-dependent kinase 1 |
66171 |
0.12 |
chr6_14673507_14673658 | 0.47 |
ENSG00000206960 |
. |
26816 |
0.27 |
chr5_141801833_141801984 | 0.47 |
AC005592.2 |
|
18125 |
0.25 |
chr11_9549283_9549434 | 0.47 |
ZNF143 |
zinc finger protein 143 |
15314 |
0.16 |
chr22_41048488_41048852 | 0.47 |
MKL1 |
megakaryoblastic leukemia (translocation) 1 |
15975 |
0.19 |
chr3_62571652_62571803 | 0.47 |
CADPS |
Ca++-dependent secretion activator |
806 |
0.77 |
chr19_42756876_42757470 | 0.47 |
ERF |
Ets2 repressor factor |
878 |
0.35 |
chr16_65443921_65444072 | 0.47 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
287728 |
0.01 |
chr3_130248087_130248238 | 0.47 |
COL6A6 |
collagen, type VI, alpha 6 |
31016 |
0.21 |
chr7_64913474_64913625 | 0.47 |
ZNF92 |
zinc finger protein 92 |
74755 |
0.1 |
chr9_79491197_79491348 | 0.47 |
PRUNE2 |
prune homolog 2 (Drosophila) |
29729 |
0.23 |
chr22_38625880_38626514 | 0.47 |
RP1-5O6.5 |
|
1129 |
0.31 |
chr1_163054379_163054530 | 0.47 |
RGS4 |
regulator of G-protein signaling 4 |
12518 |
0.25 |
chr20_10571834_10571985 | 0.47 |
JAG1 |
jagged 1 |
71245 |
0.11 |
chr3_141129614_141130038 | 0.47 |
ZBTB38 |
zinc finger and BTB domain containing 38 |
8166 |
0.24 |
chr6_130649464_130649615 | 0.47 |
SAMD3 |
sterile alpha motif domain containing 3 |
37031 |
0.18 |
chr2_161080378_161080529 | 0.47 |
ITGB6 |
integrin, beta 6 |
23638 |
0.25 |
chr10_121276847_121277401 | 0.47 |
RGS10 |
regulator of G-protein signaling 10 |
9865 |
0.25 |
chr4_77626099_77626250 | 0.47 |
RP11-359D14.2 |
|
53453 |
0.12 |
chrY_14336069_14336220 | 0.46 |
ENSG00000243980 |
. |
58033 |
0.15 |
chr13_26519130_26519281 | 0.46 |
ENSG00000242381 |
. |
573 |
0.77 |
chr20_42782277_42782428 | 0.46 |
JPH2 |
junctophilin 2 |
33381 |
0.16 |
chr12_22428603_22428754 | 0.46 |
ST8SIA1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
26698 |
0.24 |
chr3_71161769_71161920 | 0.46 |
FOXP1 |
forkhead box P1 |
17900 |
0.29 |
chr18_66474823_66474974 | 0.46 |
CCDC102B |
coiled-coil domain containing 102B |
9246 |
0.23 |
chr19_47448509_47448685 | 0.46 |
ENSG00000252071 |
. |
2949 |
0.24 |
chr3_41753251_41753402 | 0.46 |
ENSG00000252409 |
. |
23801 |
0.21 |
chr9_74299304_74300206 | 0.46 |
TMEM2 |
transmembrane protein 2 |
20093 |
0.28 |
chr18_32656273_32656556 | 0.45 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
34800 |
0.22 |
chr4_114598575_114598944 | 0.45 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
83465 |
0.11 |
chr8_30656566_30656717 | 0.45 |
PPP2CB |
protein phosphatase 2, catalytic subunit, beta isozyme |
4844 |
0.26 |
chr8_22406945_22407789 | 0.45 |
SORBS3 |
sorbin and SH3 domain containing 3 |
1841 |
0.21 |
chr1_214689137_214689772 | 0.45 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
35112 |
0.22 |
chr11_66391192_66391475 | 0.45 |
RBM14 |
RNA binding motif protein 14 |
7147 |
0.09 |
chr6_35360577_35360841 | 0.45 |
PPARD |
peroxisome proliferator-activated receptor delta |
50307 |
0.11 |
chr12_96840420_96840649 | 0.45 |
ENSG00000263364 |
. |
3276 |
0.24 |
chr17_79195686_79196550 | 0.45 |
AZI1 |
5-azacytidine induced 1 |
612 |
0.56 |
chr7_55571940_55572091 | 0.45 |
VOPP1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
11755 |
0.26 |
chr17_62612804_62612955 | 0.45 |
SMURF2 |
SMAD specific E3 ubiquitin protein ligase 2 |
45151 |
0.12 |
chr7_46584475_46584626 | 0.45 |
AC011294.3 |
Uncharacterized protein |
152170 |
0.05 |
chr8_67591677_67591944 | 0.45 |
C8orf44 |
chromosome 8 open reading frame 44 |
3356 |
0.18 |
chr3_134053758_134053909 | 0.45 |
AMOTL2 |
angiomotin like 2 |
36921 |
0.17 |
chr5_168307063_168307214 | 0.45 |
ENSG00000202345 |
. |
88635 |
0.08 |
chr1_161170632_161171366 | 0.45 |
NDUFS2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) |
938 |
0.27 |
chr7_100143162_100143602 | 0.45 |
AGFG2 |
ArfGAP with FG repeats 2 |
6500 |
0.09 |
chr2_181844204_181844974 | 0.45 |
AC104076.3 |
|
228 |
0.76 |
chr20_55008710_55009133 | 0.45 |
CASS4 |
Cas scaffolding protein family member 4 |
21604 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 0.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.1 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.3 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.1 | 0.4 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.3 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
0.1 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.2 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.3 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.2 | GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) |
0.1 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.1 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.1 | 0.1 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.4 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.1 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.2 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.5 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.5 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.2 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0060206 | estrous cycle phase(GO:0060206) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.2 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.0 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.0 | 0.0 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.0 | 0.2 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.0 | 0.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.0 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.0 | 0.0 | GO:0061042 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.3 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0090381 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.0 | 0.2 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.0 | 0.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.3 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:1902170 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.1 | GO:0034243 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.1 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.4 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.0 | GO:2000649 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.3 | GO:0050812 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0034393 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 0.0 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.0 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0060664 | mammary gland bud morphogenesis(GO:0060648) epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.0 | GO:0048641 | regulation of skeletal muscle tissue development(GO:0048641) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.0 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 0.0 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.3 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0048821 | erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
0.0 | 1.0 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.4 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.0 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.5 | GO:0072655 | establishment of protein localization to mitochondrion(GO:0072655) |
0.0 | 0.7 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.0 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.1 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.1 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.1 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.0 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.0 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.0 | 0.0 | GO:0036445 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.0 | GO:0071354 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0060581 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.0 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.0 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.9 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0043368 | positive T cell selection(GO:0043368) |
0.0 | 0.0 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.0 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0022011 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.1 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.0 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:1902579 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.0 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.1 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.3 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.0 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.0 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.0 | GO:0002420 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.0 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.0 | 0.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.5 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.5 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.6 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 1.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.2 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 3.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.0 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.4 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 1.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.6 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.0 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 1.0 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.2 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.7 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.4 | GO:0009295 | nucleoid(GO:0009295) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 3.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.1 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.5 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0019798 | procollagen-proline 3-dioxygenase activity(GO:0019797) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.1 | 0.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.3 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.5 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.6 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.1 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.3 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.4 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.0 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.0 | 0.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.0 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.6 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.6 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0030955 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.0 | 0.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.6 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 1.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 2.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.6 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 3.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 2.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 1.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |